These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2013-002248-98 Anti-CD3 MAB (Teplizumab) for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus ANTI-CD3 MAB (TEPLIZUMAB) per la prevenzione del diabete in PARENTI a rischio di sviluppare di... 2019-12-16 bad-data
Other 2013-005535-24 Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (Wegener’s) (ABROGATE) not-yet-due
Ongoing 2016-001923-30 Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus Studio sugli effetti dell'insulina orale sul sistema immunitario nei famigliari a rischio di diabete melli... not-yet-due